Morepen Laboratories Limited (NSE:MOREPENLAB)
53.29
-3.53 (-6.21%)
Jul 22, 2026, 3:29 PM IST
Morepen Laboratories Revenue
In the fiscal year ending March 31, 2026, Morepen Laboratories had annual revenue of 18.06B INR, down -0.32%. Morepen Laboratories had revenue of 4.85B in the quarter ending March 31, 2026, with 4.05% growth.
Revenue
18.06B
Revenue Growth
-0.32%
P/S Ratio
1.62
Revenue / Employee
9.95M
Employees
1,814
Market Cap
29.19B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.06B | -58.84M | -0.32% |
| Mar 31, 2025 | 18.12B | 1.21B | 7.17% |
| Mar 31, 2024 | 16.90B | 2.68B | 18.88% |
| Mar 31, 2023 | 14.22B | -1.34B | -8.60% |
| Mar 31, 2022 | 15.56B | 3.58B | 29.87% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 18.45B |
| Aarti Pharmalabs | 18.19B |
| Innova Captab | 16.30B |
| Solara Active Pharma Sciences | 13.69B |
| Windlas Biotech | 9.04B |
| Orchid Pharma | 8.11B |
| RPG Life Sciences | 7.08B |
| Ind-Swift Laboratories | 6.41B |
Morepen Laboratories News
- 15 days ago - Morepen Laboratories announces resignation of senior management personnel Bhola Prasad - Business Upturn
- 21 days ago - Morepen Laboratories shares surge over 4% as company begins commercial supplies under Rs 825 crore CDMO Mandate - Business Upturn
- 21 days ago - Morepen Laboratories completes first ₹50 crore dispatch under ₹825 crore CDMO mandate - Business Upturn
- 6 weeks ago - Morepen Laboratories shares rally sharply over 13% today: Details here - Business Upturn
- 2 months ago - Why are Morepen Lab shares falling sharply over 5% today? Explained - Business Upturn
- 2 months ago - Morepen Labs Q4 net profit surges 69% as CDMO programme enters commercial phase - Business Upturn
- 2 months ago - Morepen Laboratories appoints Vipul Kumar Srivastava as Company Secretary - Business Upturn
- 3 months ago - Morepen Laboratories secures Rs 30 crore term loan from Shinhan Bank - Business Upturn